Globus Medical (GMED) EPS (Weighted Average and Diluted) Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.39% |
| Dec 31, 2025 | 14.42% |
| Sep 30, 2025 | 14.87% |
| Jun 30, 2025 | 55.51% |
| Mar 31, 2025 | 16.65% |
| Dec 31, 2024 | -15.46% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -9.55% |
| Mar 31, 2024 | -16.56% |
| Dec 31, 2023 | -24.21% |
| Sep 30, 2023 | -50.89% |
| Jun 30, 2023 | 5.31% |
| Mar 31, 2023 | 4.24% |
| Dec 31, 2022 | 14.41% |
| Sep 30, 2022 | 12.57% |
| Jun 30, 2022 | 12.82% |
| Mar 31, 2022 | 4.28% |
| Dec 31, 2021 | -10.95% |
| Sep 30, 2021 | 10.76% |
| Jun 30, 2021 | 8.18% |
| Mar 31, 2021 | 8.70% |
| Dec 31, 2020 | 5.92% |
| Sep 30, 2020 | 9.46% |
| Jun 30, 2020 | -23.22% |
| Mar 31, 2020 | -0.78% |
| Dec 31, 2019 | 8.70% |
| Sep 30, 2019 | 9.63% |
| Jun 30, 2019 | 11.55% |
| Mar 31, 2019 | 8.45% |
| Dec 31, 2018 | 10.35% |
| Sep 30, 2018 | 9.73% |
| Jun 30, 2018 | 40.63% |
| Mar 31, 2018 | 13.18% |
| Dec 31, 2017 | 2.59% |
| Sep 30, 2017 | 7.63% |
| Jun 30, 2017 | 6.67% |
| Mar 31, 2017 | 9.57% |
| Dec 31, 2016 | 10.76% |
| Sep 30, 2016 | 7.28% |
| Jun 30, 2016 | 8.45% |